You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 26, 2024

Details for Patent: 7,056,893


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,056,893
Title:Topical treatment for prevention of ocular infections
Abstract:Azalide antibiotics such as azithromycin are useful in the treatment and prevention of infections by bacteria and other parasites. Stabilized aqueous compositions containing azithromycin suitable for administration without reconstitution are provided for. Also provided for are aqueous formulations suitable for ocular administration in a employing a convenient dosing formulation suitable for administration in depot formats.
Inventor(s): Roy; Samir (San Ramon, CA), Bowman; Lyle M. (Pleasanton, CA)
Assignee: Insite Vision, Inc. (Alameda, CA)
Application Number:10/160,060
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Use;
Patent landscape, scope, and claims:

United States Patent 7,056,893: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 7,056,893, titled "Topical treatment for prevention of ocular infections," is a significant patent in the field of ophthalmic treatments, particularly involving azalide antibiotics. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this patent.

Background and Invention

The patent, issued to its inventors, describes a topical ophthalmic composition and a process for treating ocular infections using azalide antibiotics, such as azithromycin. Azalide antibiotics are known for their efficacy against bacterial and parasitic infections, and this patent specifically addresses their application in preventing and treating ocular infections[4].

Scope of the Patent

The scope of the patent is defined by its claims, which outline the specific aspects of the invention that are protected. Here are some key points:

  • Claims Coverage: The patent includes multiple claims that cover the composition of the topical ophthalmic formulation, the method of preparation, and the method of treating ocular infections using this formulation. For instance, claims 1-13, 23-27, 29-34, and 36-44 are specifically mentioned in litigation documents as being relevant to the invention[2].

  • Active Ingredients: The patent emphasizes the use of azalide antibiotics, particularly azithromycin, as the active ingredient in the topical treatment. This is a crucial aspect of the invention, as it highlights the therapeutic efficacy of these antibiotics in ocular infections.

  • Method of Treatment: The patent also covers the method of treating ocular infections, including the application of the topical ophthalmic composition and the dosage regimen.

Claims Analysis

The claims of the patent are the heart of its protection and define what is novel and non-obvious about the invention.

Independent Claims

Independent claims are those that stand alone and do not depend on other claims. For example, Claim 1 might describe the composition of the topical ophthalmic formulation, while Claim 23 might describe a specific method of treating an ocular infection using this formulation.

Dependent Claims

Dependent claims build upon independent claims and provide additional details or limitations. These claims help to narrow down the scope of protection and can be used to defend against infringement by showing that an accused product or method falls within the scope of these dependent claims.

Patent Landscape

Understanding the patent landscape around U.S. Patent 7,056,893 involves looking at related patents, international filings, and the broader intellectual property environment.

Related Patents

Other patents related to ocular treatments and azalide antibiotics are part of the same patent family or are filed by the same inventors. For instance, patents like U.S. Patent Nos. 6,239,113 and 6,569,443 also claim topical ophthalmic compositions and processes, indicating a robust portfolio in this area[5].

International Filings

To assess global protection, it is essential to look at international filings. The Global Dossier service provided by the USPTO allows users to see the patent family for a specific application, including related applications filed at participating IP Offices. This helps in understanding the global reach of the patent protection[1].

Competitor Patents

Analyzing competitor patents in the same field can reveal gaps or opportunities. Patent analytics tools, such as those described by Schwegman, can help categorize patents by claims and scope concepts, making it easier to identify where competitors may have overlapping or distinct claims[3].

Litigation and Enforcement

The patent has been involved in litigation, particularly in cases related to generic drug manufacturers. For example, Mylan Pharmaceuticals was accused of patent infringement for filing an Abbreviated New Drug Application (ANDA) that included a Paragraph IV certification challenging the validity of the patent claims. This litigation highlights the importance of enforcing patent rights to protect intellectual property[2].

Claim Charts and Coverage Analysis

Using tools like ClaimScape® software, companies can generate interactive claim charts to review patent coverage. These charts help technical experts determine whether a particular scope concept is applicable to a target product or method, identifying gaps in current coverage and highlighting future design opportunities. This analysis is crucial for maintaining and expanding the patent portfolio[3].

Future Directions and Opportunities

The patent landscape around U.S. Patent 7,056,893 suggests several future directions:

  • Continued Innovation: The use of azalide antibiotics in ocular treatments is an area of ongoing research. Future patents may cover new formulations, delivery methods, or additional therapeutic applications.

  • Global Expansion: Ensuring that the patent is protected in key international markets through strategic filings and maintenance is essential for global market domination.

  • Competitive Analysis: Regularly monitoring competitor patents and filings can help identify potential threats and opportunities for differentiation.

Key Takeaways

  • Scope and Claims: The patent covers a topical ophthalmic composition and method of treating ocular infections using azalide antibiotics.
  • Patent Landscape: The patent is part of a broader portfolio related to ocular treatments and has international filings.
  • Litigation: The patent has been involved in significant litigation related to generic drug applications.
  • Future Directions: Continued innovation, global expansion, and competitive analysis are key to maintaining and expanding the patent portfolio.

FAQs

What is the main subject of U.S. Patent 7,056,893?

The main subject of U.S. Patent 7,056,893 is a topical ophthalmic composition and a method for treating ocular infections using azalide antibiotics, such as azithromycin.

How do claim charts help in patent analysis?

Claim charts help in patent analysis by categorizing patents by claims and scope concepts, making it easier to identify gaps in current coverage, highlight future design opportunities, and review patent coverage with technical experts.

What is the significance of the Global Dossier service in patent analysis?

The Global Dossier service allows users to see the patent family for a specific application, including related applications filed at participating IP Offices, providing a comprehensive view of global patent protection.

Why is litigation important for patent enforcement?

Litigation is crucial for enforcing patent rights and protecting intellectual property. It helps in preventing unauthorized use of the patented invention and ensures that competitors do not infringe on the patent claims.

How can companies use patent analytics to manage their patent portfolios?

Companies can use patent analytics to track patents by claims and scope concepts, identify gaps or opportunities in their patent coverage, and make informed decisions about maintaining or expanding their patent portfolios.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,056,893

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.